MITOXANTRONE INJECTION USP
PFIZER CANADA ULC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is MITOXANTRONE INJECTION USP discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that MITOXANTRONE INJECTION USP 2MG has been permanently discontinued (last updated July 31, 2020). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is MITOXANTRONE INJECTION USP not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
MITOXANTRONE INJECTION
FRESENIUS KABI CANADA LTD
Other Products
NOVANTRONE INJ 2MG/ML
LEDERLE CYANAMID CANADA INC.
NOVANTRONE
WYETH CANADA
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02244614
Strength
2MG
Dosage Form
SOLUTION
Route
INTRAVENOUS
Active Ingredient
MITOXANTRONE
Tier
Unrated
Last Updated
2020-07-31
Reason for Shortage
Business reasons
Other Products from PFIZER CANADA ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
40MG · DIN 02511053
20MG · DIN 02511061
40MG · DIN 02511045
DIN 02544040
5MG · DIN 01947664
10MG · DIN 01947672
20MG · DIN 01947680
40MG · DIN 01947699
DIN 02237367
DIN 02237368
DIN 02237369
50MG · DIN 02401347